Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 7
1974 1
1975 5
1976 5
1977 6
1978 3
1979 1
1980 2
1981 3
1982 4
1983 4
1984 3
1985 6
1986 5
1987 8
1988 6
1989 7
1990 15
1991 9
1992 4
1993 8
1994 7
1995 4
1996 9
1997 9
1998 11
1999 7
2000 9
2001 4
2002 9
2003 10
2004 8
2005 4
2006 4
2007 2
2008 5
2009 7
2010 13
2011 9
2012 12
2013 6
2014 3
2015 6
2016 5
2017 3
2018 3
2019 4
2020 6
2021 2
2022 7
2023 1
2024 4
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

296 results

Results by year

Filters applied: . Clear all
Page 1
Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical Trial.
Fung CH, Alessi C, Martin JL, Josephson K, Kierlin L, Dzierzewski JM, Moore AA, Badr MS, Zeidler M, Kelly M, Smith JP, Cook IA, Der-Mcleod E, Ghadimi S, Naeem S, Partch L, Guzman A, Grinberg A, Mitchell M. Fung CH, et al. JAMA Intern Med. 2024 Dec 1;184(12):1448-1456. doi: 10.1001/jamainternmed.2024.5020. JAMA Intern Med. 2024. PMID: 39374004 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial conducted at an academic medical center and a Department of Veterans Affairs medical center included adults aged 55 years or older who had used lorazepam, alprazolam, clonazepam, temazepam, and/or zolpidem f …
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial conducted at an academic medical center and a Department of Veterans Affai …
Clonazepam.
Browne TR. Browne TR. N Engl J Med. 1978 Oct 12;299(15):812-6. doi: 10.1056/NEJM197810122991505. N Engl J Med. 1978. PMID: 99652 Clinical Trial. No abstract available.
Anticonvulsant drug hypersensitivity.
Galindo PA, Borja J, Gómez E, Mur P, Gudín M, García R, Encinas C, Romero G, Garrido JA, Cortina P, Feo F. Galindo PA, et al. J Investig Allergol Clin Immunol. 2002;12(4):299-304. J Investig Allergol Clin Immunol. 2002. PMID: 12926190 Clinical Trial.
The drugs tolerated were sodium valproate (6 patients), topiramate (4), vigabatrin (2), lamotrigine (1), clonazepam (1), and gabapentin (1). We found 12 positive patch tests: 6 with carbamazepine, 3 with phenytoin and, 1 each with lamotrigine, sodium valproate and phenobar …
The drugs tolerated were sodium valproate (6 patients), topiramate (4), vigabatrin (2), lamotrigine (1), clonazepam (1), and gabapent …
Safety and efficacy of clonazepam in patients with hemifacial spasm: A double-blind, randomized, placebo-controlled trial.
Baek SH, Shin JY, Sohn SY, Park KH, Kim JS, Kim B, Ahn SH, Choi K, Hong YH, Sung JJ. Baek SH, et al. Parkinsonism Relat Disord. 2022 Oct;103:1-6. doi: 10.1016/j.parkreldis.2022.07.025. Epub 2022 Aug 6. Parkinsonism Relat Disord. 2022. PMID: 35987013 Clinical Trial.
Medical and surgical treatments can be considered for HFS. Among medical treatments, clonazepam is a benzodiazepine used to treat epilepsy, psychiatric symptoms, and movement disorders. ...CONCLUSION: The results of this study demonstrated the safety of clonazepam i …
Medical and surgical treatments can be considered for HFS. Among medical treatments, clonazepam is a benzodiazepine used to treat epi …
Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures.
Mikkelsen B, Birket-Smith E, Bradt S, Holm P, BParm, Lung M, Thorn I, Vestermark S, Olsen PZ. Mikkelsen B, et al. Arch Neurol. 1976 May;33(5):322-5. doi: 10.1001/archneur.1976.00500050008002. Arch Neurol. 1976. PMID: 817696 Clinical Trial.
The effects of the combined use of clonazepam and the previous antiepileptid drugs were compared with the effects of placebo combined with the same drugs. ...Mental sideeffects such as agitation, confusion, and aggressiveness were more troublesome and caused discontinuatio …
The effects of the combined use of clonazepam and the previous antiepileptid drugs were compared with the effects of placebo combined …
Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson's disease and sleep disorders: a randomized, double-blind trial.
Hadi F, Agah E, Tavanbakhsh S, Mirsepassi Z, Mousavi SV, Talachi N, Tafakhori A, Aghamollaii V. Hadi F, et al. Neurol Sci. 2022 Oct;43(10):6141-6148. doi: 10.1007/s10072-022-06188-4. Epub 2022 Jun 6. Neurol Sci. 2022. PMID: 35660990 Clinical Trial.
Melatonin intake was associated with a higher decrease in RBDSQ score compared to trazodone (P = 0.011) and clonazepam (P = 0.004). Trazodone intake was associated with a higher decrease in ESS score compared to clonazepam (P = 0.010). Mild adverse events were repor …
Melatonin intake was associated with a higher decrease in RBDSQ score compared to trazodone (P = 0.011) and clonazepam (P = 0.004). T …
Oral clonazepam versus lorazepam in the treatment of methamphetamine-poisoned children: a pilot clinical trial.
Farnaghi F, Rahmani R, Hassanian-Moghaddam H, Zamani N, McDonald R, Gholami N, Gachkar L. Farnaghi F, et al. BMC Pediatr. 2020 Dec 3;20(1):543. doi: 10.1186/s12887-020-02441-x. BMC Pediatr. 2020. PMID: 33267837 Free PMC article. Clinical Trial.
OBJECTIVES: To evaluate the efficacy of oral clonazepam versus oral lorazepam following initial parenteral benzodiazepine administration to control methamphetamine-induced agitation in children. ...There was no report of benzodiazepine complications in either group. CONCLU …
OBJECTIVES: To evaluate the efficacy of oral clonazepam versus oral lorazepam following initial parenteral benzodiazepine administrat …
Psychometric Assessment of Clinical Factors in Burning Mouth Syndrome Progression.
Garcia-Martinez A, Tvarijonaviciute A, López-Jornet P. Garcia-Martinez A, et al. Int Dent J. 2025 Aug;75(4):100838. doi: 10.1016/j.identj.2025.100838. Epub 2025 May 30. Int Dent J. 2025. PMID: 40449129 Free PMC article. Clinical Trial.
MATERIALS AND METHODS: A total of 86 women with BMS were divided into 4 groups: laser plus clonazepam (n = 24), sham laser placebo (n = 20), laser only (n = 22), and clonazepam only (n = 20). ...
MATERIALS AND METHODS: A total of 86 women with BMS were divided into 4 groups: laser plus clonazepam (n = 24), sham laser placebo (n …
The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial.
Herman CR, Schiffman EL, Look JO, Rindal DB. Herman CR, et al. J Orofac Pain. 2002 Winter;16(1):64-70. J Orofac Pain. 2002. PMID: 11889661 Clinical Trial.
Subjects were randomized into 1 of 3 groups: clonazepam (0.5 mg/night), cyclobenzaprine (10 mg/night), or placebo. The primary outcome measure was the subjects' average intensity of jaw pain upon awakening over the prior week. ...Between-group differences demonstrated a st …
Subjects were randomized into 1 of 3 groups: clonazepam (0.5 mg/night), cyclobenzaprine (10 mg/night), or placebo. The primary outcom …
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
Nardi AE, Valença AM, Freire RC, Mochcovitch MD, Amrein R, Sardinha A, Levitan MN, Nascimento I, de-Melo-Neto VL, King AL, de O E Silva AC, Veras AB, Dias GP, Soares-Filho GL, da Costa RT, Mezzasalma MA, de Carvalho MR, de Cerqueira AC, Hallak JE, Crippa JA, Versiani M. Nardi AE, et al. Braz J Med Biol Res. 2011 Apr;44(4):366-73. doi: 10.1590/s0100-879x2011007500020. Epub 2011 Feb 18. Braz J Med Biol Res. 2011. PMID: 21344132 Free article. Clinical Trial.
Most patients were females (69.8 and 68.4% in the clonazepam and paroxetine groups, respectively) and age (mean SD) was 35.9 9.6 years for the clonazepam group and 33.7 8.8 years for the paroxetine group. ...Patients treated with clonazepam had fewer ad …
Most patients were females (69.8 and 68.4% in the clonazepam and paroxetine groups, respectively) and age (mean SD) was 35.9 9.6 …
296 results